WO1993025530A2 - Vinyl arenas having retinoid-like activity - Google Patents
Vinyl arenas having retinoid-like activity Download PDFInfo
- Publication number
- WO1993025530A2 WO1993025530A2 PCT/US1993/005153 US9305153W WO9325530A2 WO 1993025530 A2 WO1993025530 A2 WO 1993025530A2 US 9305153 W US9305153 W US 9305153W WO 9325530 A2 WO9325530 A2 WO 9325530A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oder
- diyl
- und
- die
- der
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Definitions
- M 1 , M 2 , M 3 , M 4 gleich oder accru -O-, -S-, -CO-, -CO-O-, -O-CO-, -CO-S-, -S-CO-, -O-CO-O-, -CH 2 -O-, -O-CH 2 -, -CH 2 -CH 2 ., -CH CH- Oder -C ⁇ C-;
- M 1 , M 2 , M 3 , M 4 gleich oder every, -O-, -CO-, -CO-O-, -O-CO-, -CH 2 -O-, -O-CH 2 -, -CH 2 -CH 2 -, -CH CH- oder -C ⁇ C-;
- M 1 , M 2 , M 3 , M 4 gleich oder accru -0-, -CO-O-, -O-CO-, -O-CH 2 -, -CH 2 -O-, -CH 2 -CH 2 - oder -CH CH-;
- M 1 , M 2 , M 3 , M 4 Sind gleich oder originally, -O-, -CO-O-, -O-CO-, -OCH 2 -, -CH 2 -O- oder -C H2 CH 2 -;
- R 8 geradkettiges oder verzweigtes Alkyl mit 1 bis 10 C-Atomen
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93915168A EP0649409A1 (en) | 1992-06-11 | 1993-06-01 | Vinyl arenas having retinoid-like activity |
CA002137819A CA2137819A1 (en) | 1992-06-11 | 1993-06-01 | Vinyl arenas having retinoid-like activity |
JP50153294A JP3520085B2 (en) | 1992-06-11 | 1993-06-01 | Vinyl arene with retinoid-like activity |
AU45255/93A AU687741B2 (en) | 1992-06-11 | 1993-06-01 | Vinyl arenas having retinoid-like activity |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/898,764 US5324840A (en) | 1992-06-11 | 1992-06-11 | Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
US07/898,764 | 1992-06-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1993025530A2 true WO1993025530A2 (en) | 1993-12-23 |
WO1993025530A3 WO1993025530A3 (en) | 1994-03-17 |
Family
ID=25410009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/005153 WO1993025530A2 (en) | 1992-06-11 | 1993-06-01 | Vinyl arenas having retinoid-like activity |
Country Status (9)
Country | Link |
---|---|
US (3) | US5324840A (en) |
EP (1) | EP0649409A1 (en) |
JP (2) | JP3520085B2 (en) |
CN (1) | CN1144091A (en) |
AU (1) | AU687741B2 (en) |
CA (1) | CA2137819A1 (en) |
IL (1) | IL105937A (en) |
WO (1) | WO1993025530A2 (en) |
ZA (1) | ZA933994B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5798372A (en) * | 1995-03-20 | 1998-08-25 | Allergan | Method for preventing onset of restenosis after angioplasty employing a retinoid |
EP0909560A2 (en) * | 1993-03-11 | 1999-04-21 | Allergan, Inc. | Treatment o tumors with compounds having RXR retinoid receptor agoinst activity |
WO2002004439A2 (en) * | 2000-07-10 | 2002-01-17 | F. Hoffmann-La Roche Ag | Thiophene retinoids |
US10406088B2 (en) | 2015-01-20 | 2019-09-10 | TetraDerm Group LLC | Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264578A (en) * | 1987-03-20 | 1993-11-23 | Allergan, Inc. | Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
US5602130A (en) * | 1987-03-20 | 1997-02-11 | Allergan | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
US5272156A (en) * | 1989-09-19 | 1993-12-21 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5183827A (en) * | 1989-09-19 | 1993-02-02 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5264456A (en) * | 1989-12-29 | 1993-11-23 | Allergan, Inc. | Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity |
US5968989A (en) * | 1991-12-18 | 1999-10-19 | The Salk Institute For Biological Studies | Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
US7056954B2 (en) * | 1991-12-18 | 2006-06-06 | The Salk Institute For Biological Studies | Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
US5324840A (en) * | 1992-06-11 | 1994-06-28 | Allergan, Inc. | Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
US6172115B1 (en) | 1993-02-11 | 2001-01-09 | Allergan Sales, Inc. | Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid |
US5455265A (en) * | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
CA2129773C (en) * | 1993-09-02 | 2007-05-01 | Michael Klaus | Aromatic carboxylic acid derivatives |
US5475022A (en) * | 1993-10-18 | 1995-12-12 | Allergan, Inc. | Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
US5426118A (en) * | 1993-12-30 | 1995-06-20 | Allergan, Inc. | [4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity |
US5498755A (en) * | 1994-08-23 | 1996-03-12 | Chandraratna; Roshantha A. | Disubstituted aryl and heteroaryl imines having retinoid-like biological activity |
US5618943A (en) * | 1994-12-29 | 1997-04-08 | Allergan | Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity |
US5543534A (en) * | 1994-12-29 | 1996-08-06 | Allergan | Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
US5534641A (en) * | 1994-12-29 | 1996-07-09 | Allergan | Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity |
US5599967A (en) * | 1994-12-29 | 1997-02-04 | Allergan | Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity |
US5514825A (en) * | 1994-12-29 | 1996-05-07 | Allergan, Inc. | Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity |
US5648514A (en) | 1994-12-29 | 1997-07-15 | Allergan | Substituted acetylenes having retinoid-like biological activity |
US5556996A (en) * | 1994-12-29 | 1996-09-17 | Allergan | Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity |
US5489584A (en) * | 1994-12-29 | 1996-02-06 | Allergan, Inc. | Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity |
US5618931A (en) * | 1994-12-29 | 1997-04-08 | Allergan | Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity |
US5559248A (en) * | 1995-04-05 | 1996-09-24 | Bristol-Myers Squibb Co. | Retinoid-like heterocycles |
US6025388A (en) * | 1995-04-26 | 2000-02-15 | Allergan Sales, Inc. | Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
US5616712A (en) * | 1995-05-16 | 1997-04-01 | Allergan | Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity |
US5675033A (en) | 1995-06-06 | 1997-10-07 | Allergan | 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
US5917082A (en) * | 1995-06-06 | 1999-06-29 | Allergan Sales, Inc. | 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
US5952345A (en) * | 1995-09-01 | 1999-09-14 | Allergan Sales, Inc. | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
US6008204A (en) * | 1995-09-01 | 1999-12-28 | Allergan Sales, Inc. | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
US6218128B1 (en) | 1997-09-12 | 2001-04-17 | Allergan Sales, Inc. | Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities |
US5958954A (en) * | 1995-09-01 | 1999-09-28 | Allergan Sales, Inc. | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
US6942980B1 (en) | 1995-09-01 | 2005-09-13 | Allergan, Inc. | Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities |
AU7598596A (en) * | 1995-11-01 | 1997-05-22 | Allergan, Inc. | Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity |
US5675024A (en) | 1995-11-22 | 1997-10-07 | Allergan | Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity |
US5663357A (en) | 1995-11-22 | 1997-09-02 | Allergan | Substituted heteroarylamides having retinoid-like biological activity |
US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
US5688957A (en) * | 1995-12-29 | 1997-11-18 | Allergan | (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity |
US20030219832A1 (en) * | 1996-03-11 | 2003-11-27 | Klein Elliott S. | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
US5808124A (en) * | 1996-06-21 | 1998-09-15 | Allergan | O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
US5763635A (en) * | 1996-06-21 | 1998-06-09 | Allergan | Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity |
US5747542A (en) * | 1996-06-21 | 1998-05-05 | Allergan | Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity |
AU724541B2 (en) * | 1996-06-21 | 2000-09-21 | Allergan, Inc. | Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
US6555690B2 (en) * | 1996-06-21 | 2003-04-29 | Allergan, Inc. | Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
US5723666A (en) * | 1996-06-21 | 1998-03-03 | Allergan | Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
US5741896A (en) * | 1996-06-21 | 1998-04-21 | Allergan | O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
US5773594A (en) * | 1996-06-21 | 1998-06-30 | Allergan | Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
US5739338A (en) * | 1996-11-05 | 1998-04-14 | Allergan | N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity |
US5728846A (en) | 1996-12-12 | 1998-03-17 | Allergan | Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives |
US5760276A (en) * | 1997-03-06 | 1998-06-02 | Allergan | Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
AU6895198A (en) * | 1997-04-11 | 1998-11-11 | Sidney Kimmel Cancer Center | Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease |
US6037488A (en) * | 1997-04-19 | 2000-03-14 | Allergan Sales, Inc. | Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
US5919970A (en) | 1997-04-24 | 1999-07-06 | Allergan Sales, Inc. | Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity |
JP4398585B2 (en) * | 1997-11-12 | 2010-01-13 | 有限会社ケムフィズ | Retinoid receptor agonist |
EP1324970B1 (en) | 2000-10-02 | 2008-11-05 | F. Hoffmann-La Roche Ag | Retinoids for the treatment of emphysema |
US6720423B2 (en) | 2002-04-30 | 2004-04-13 | Allergan, Inc. | Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
US7649098B2 (en) * | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
US8293803B2 (en) * | 2006-08-29 | 2012-10-23 | Reinnervate Limited | Retinoid compounds and their use |
TW200920355A (en) * | 2007-09-06 | 2009-05-16 | Lexicon Pharmaceuticals Inc | Compositions and methods for treating immunological and inflammatory diseases and disorders |
CN107250112B (en) * | 2014-10-10 | 2021-04-23 | 高力研究有限公司 | Fluorescent synthetic retinoids |
ES2898676T3 (en) | 2015-11-25 | 2022-03-08 | Io Therapeutics Inc | Selective CYP26-resistant rar-alpha agonists in cancer treatment |
AU2017278220C1 (en) | 2016-06-10 | 2022-10-13 | Io Therapeutics, Inc. | Receptor selective retinoid and rexinoid compounds and immune modulators for cancer immunotherapy |
JP2020526551A (en) | 2017-07-13 | 2020-08-31 | アイオー セラピューティクス インコーポレイテッド | Immunomodulatory retinoid and lexinoid compounds combined with immunomodulators for cancer immunotherapy |
CA3073953A1 (en) | 2017-08-31 | 2019-03-07 | Io Therapeutics, Inc. | Rar selective agonists in combination with immune modulators for cancer immunotherapy |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4326055A (en) * | 1977-12-22 | 1982-04-20 | Hoffmann-La Roche Inc. | Stilbene derivatives |
EP0176032A2 (en) * | 1984-09-22 | 1986-04-02 | BASF Aktiengesellschaft | Tetralin derivatives, their preparation and use |
EP0210929A2 (en) * | 1985-07-25 | 1987-02-04 | Centre International De Recherches Dermatologiques Galderma - Cird Galderma | Aromatic polycyclic derivatives, process for their preparation and their pharmaceutical and cosmetic use |
EP0245825A1 (en) * | 1986-05-09 | 1987-11-19 | Warner-Lambert Company | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
DE3715955A1 (en) * | 1986-05-23 | 1987-11-26 | Hoffmann La Roche | TETRAHYDRONAPHTHALINE AND INDANDERIVATES |
EP0253302A2 (en) * | 1986-07-15 | 1988-01-20 | F. Hoffmann-La Roche Ag | Tetrahydronaphthalène and indane derivatives, their synthesis and application in pharmaceutical preparations |
US4723028A (en) * | 1984-07-07 | 1988-02-02 | Koichi Shudo | Stilbene derivatives |
EP0303915A2 (en) * | 1987-08-19 | 1989-02-22 | F. Hoffmann-La Roche Ag | Retinoids for the treatment of skin damaged by light |
WO1991016051A1 (en) * | 1990-04-16 | 1991-10-31 | Rhône-Poulenc Rorer International (Holdings) Inc. | Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4085091A (en) * | 1976-12-16 | 1978-04-18 | E. I. Dupont De Nemours And Company | Thermally stable, rigid polyesters from thermally stable, rigid dibasic acids and aromatic dihydroxy compounds |
EP0047817A3 (en) * | 1980-08-14 | 1982-05-26 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Hydrogenated naphthalines, their preparation and application, and mixtures containing such naphthalines |
CH651034A5 (en) * | 1982-05-12 | 1985-08-30 | Hoffmann La Roche | CHROMAN, THIOCHROMAN OR 1,2,3,4-TETRAHYDROCHINOLIN DERIVATIVES AND THEIR USE AS MEDICINAL ACTIVE SUBSTANCES. |
US4420583A (en) * | 1982-06-24 | 1983-12-13 | Rohm And Haas Company | Acid containing emulsion copolymer crosslinked by a halohydroxypropyl ammonium salt solution polymer |
DK158947C (en) * | 1982-07-06 | 1991-01-21 | Hoffmann La Roche | TETRAHYDRONAPHTHALIN, BENZOFURAN AND BENZOTHIOPHENDER DERIVATIVES, PREPARATION AND USE THEREOF, AND RODENTICID CONTAINING SUCH DERIVATIVES |
ATE38835T1 (en) * | 1983-07-05 | 1988-12-15 | Pfizer | CARBONIC ACID DERIVATIVES USEFUL IN PREVENTING DECOMPOSITION OF CARTILAGE. |
WO1985000806A1 (en) * | 1983-08-08 | 1985-02-28 | Sri International | Benzonorbornenyl, benzopyranyl and benzothiopyranyl retinoic acid analogues |
FR2562539B1 (en) * | 1984-04-06 | 1987-04-17 | Chauvin Blache Lab | NOVEL VINYL-4 BENZOIC ACID DERIVATIVES, PREPARATION METHOD THEREOF AND THERAPEUTIC APPLICATIONS THEREOF AND AS LIGANDS |
US4826984A (en) * | 1984-04-09 | 1989-05-02 | The Board Of Regents For The Oklahoma Agricultural And Mechanical College Acting For And On Behalf Of Oklahoma State University | Heteroarotinoid compounds as anticancer agents |
JPS60222445A (en) * | 1984-04-19 | 1985-11-07 | Yoshitomi Pharmaceut Ind Ltd | Phthalic acid compound |
DE3580134D1 (en) * | 1984-07-07 | 1990-11-22 | Shudo Koichi Prof Dr Chem | BENZOESAEUR DERIVATIVES. |
CH667868A5 (en) * | 1984-09-05 | 1988-11-15 | Oreal | BENZONORBORNENE DERIVATIVES, PREPARATION METHODS THEREOF, AND MEDICINAL AND COSMETIC COMPOSITIONS CONTAINING THEM. |
LU85544A1 (en) * | 1984-09-19 | 1986-04-03 | Cird | AROMATIC HETEROCYCLIC DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THE THERAPEUTIC AND COSMETIC FIELDS |
DE3434946A1 (en) * | 1984-09-22 | 1986-04-03 | Basf Ag, 6700 Ludwigshafen | DIARYLACETYLENE, THEIR PRODUCTION AND USE |
DE3434947A1 (en) * | 1984-09-22 | 1986-04-03 | Basf Ag, 6700 Ludwigshafen | ISOXAZOLIC CARBONIC ACID DERIVATIVES, THEIR PRODUCTION AND USE |
LU85558A1 (en) * | 1984-09-28 | 1986-04-03 | Oreal | NOVEL RETINOICALLY ACTIVE NAPHTHALENIC DERIVATIVES, PREPARATION METHODS THEREOF, AND MEDICINAL AND COSMETIC COMPOSITIONS CONTAINING THEM |
ES8801209A1 (en) * | 1985-06-18 | 1988-01-01 | Merck Frosst Canada Inc | 2-Substituted quinolines, their preparation and use. |
IL80270A0 (en) * | 1985-10-11 | 1987-01-30 | Cird | Naphthalene derivatives,their preparation and pharmaceutical compositions containing them |
DE3602473A1 (en) * | 1986-01-28 | 1987-07-30 | Basf Ag | VINYLPHENOL DERIVATIVES, THEIR PRODUCTION AND USE |
LU86351A1 (en) * | 1986-03-12 | 1987-11-11 | Oreal | BENZOPYRANNYL AND BENZOTHIOPYRANNYL BENZOIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COSMETICS AND HUMAN AND VETERINARY MEDICINE |
DE3615157A1 (en) * | 1986-05-05 | 1987-11-12 | Schwabe Willmar Gmbh & Co | 5-ARYLALKYL-4-ALKOXY-2 (5H) -FURANONE, INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS THERAPEUTIC ACTIVE SUBSTANCES |
ZW6587A1 (en) * | 1986-05-13 | 1987-12-02 | Hoffmann La Roche | Tetrahydro naphthanline derivatives |
US4739098A (en) * | 1986-09-22 | 1988-04-19 | Allergan, Inc. | Ethynylphenyl-containing retinoic acid derivatives |
NZ222968A (en) | 1986-12-24 | 1990-05-28 | Allergan Inc | Ethynylheteroaromatic derivatives and medicaments |
US4927947A (en) | 1986-12-24 | 1990-05-22 | Allergan, Inc. | Ethynylheteroaromatic-acids having retinoic acid-like activity |
AT388728B (en) * | 1987-03-17 | 1989-08-25 | Hoffmann La Roche | NEW TETRAHYDRONAPHTHALINE AND INDANDERIVATIVES |
CA1305480C (en) * | 1987-03-20 | 1992-07-21 | Roshantha A.S. Chandraratna | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
US5234926A (en) | 1987-03-20 | 1993-08-10 | Allergan, Inc. | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
US5264578A (en) | 1987-03-20 | 1993-11-23 | Allergan, Inc. | Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
US5089509A (en) * | 1988-09-15 | 1992-02-18 | Allergan, Inc. | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
US4810804A (en) * | 1987-03-26 | 1989-03-07 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid-like activity |
US4833254A (en) * | 1987-05-11 | 1989-05-23 | The Board Of Regents For The Oklahoma Agricultural And Mechanical Colleges Acting For And On Behalf Of Oklahoma State University | Heteroarotinoids as anticancer agents |
CA1298309C (en) * | 1987-11-06 | 1992-03-31 | Michael Klaus | Benzocycloheptene derivatives |
US5231113A (en) | 1988-04-11 | 1993-07-27 | Allergan, Inc. | Tetralin esters of phenols or benzoic acids having retinoid like activity |
KR0139216B1 (en) * | 1988-04-11 | 1998-05-01 | 제임스 엠. 캐내지 | Tetralin esters of phenols or benzoic acids having retinoic like activity |
US4895868A (en) * | 1988-06-29 | 1990-01-23 | Allergan, Inc. | Thiochroman esters of phenols and terephthallates having retinoid-like activity |
US5015658A (en) * | 1988-06-29 | 1991-05-14 | Allergan, Inc. | Thiochroman esters of phenols and terephthallates having retinoid-like activity |
AU626881B2 (en) * | 1988-07-14 | 1992-08-13 | F. Hoffmann-La Roche Ag | Benzofused heterocyclics used as pharmaceuticals |
US5053253A (en) | 1988-09-07 | 1991-10-01 | Minnesota Mining And Manufacturing Company | Skid-resistant pavement markings |
US4992468A (en) * | 1989-07-26 | 1991-02-12 | Allergan, Inc. | Phenylethenyl compounds having retinoid-like activity |
US5068252A (en) * | 1989-07-26 | 1991-11-26 | Allergan, Inc. | Methods of using phenylethenyl compounds having retinoid-like activity |
US5248777A (en) | 1989-09-19 | 1993-09-28 | Allergan, Inc. | Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
US5053523A (en) * | 1989-09-19 | 1991-10-01 | Allergan, Inc. | Ethynyl-chroman compounds |
US5162546A (en) | 1989-09-19 | 1992-11-10 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5045551A (en) * | 1989-09-19 | 1991-09-03 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5023341A (en) * | 1989-09-19 | 1991-06-11 | Allergan, Inc. | Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
US5272156A (en) | 1989-09-19 | 1993-12-21 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5183827A (en) | 1989-09-19 | 1993-02-02 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US4980369A (en) * | 1989-09-19 | 1990-12-25 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl or thiochromanyl group having retinoid-like activity |
US5013744B1 (en) * | 1989-12-29 | 1994-09-20 | Allegran Inc | Acetylenes disubstituted with a pyridinyl group and a substituted phenyl group having retinoid like activity |
US5264456A (en) | 1989-12-29 | 1993-11-23 | Allergan, Inc. | Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity |
US5175185A (en) | 1989-12-29 | 1992-12-29 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity |
US5006550A (en) * | 1989-12-29 | 1991-04-09 | Allergan, Inc. | Chroman esters of phenols and benzoic acids having retinoid-like activity |
US5202471A (en) | 1990-02-06 | 1993-04-13 | Allergan, Inc. | Alkyl, alkoxy and thioalkoxy substituted diphenyl acetylenes having retinoid like activity |
US5068523A (en) | 1990-03-02 | 1991-11-26 | Intec Corp. | Scanner detector array and light diffuser |
GB9009446D0 (en) * | 1990-04-26 | 1990-06-20 | Beecham Group Plc | Veterinary composition |
LU87821A1 (en) * | 1990-10-12 | 1992-05-25 | Cird Galderma | BI-AROMATIC COMPOUNDS, AND THEIR USE IN HUMAN AND VETERINARY MEDICINE AND IN COSMETICS |
US5134159A (en) * | 1991-03-26 | 1992-07-28 | Allergan, Inc. | 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
US5326898A (en) * | 1992-02-11 | 1994-07-05 | Allergan, Inc. | Substituted phenylethenyl compounds having retinoid-like biological activity |
US5324840A (en) * | 1992-06-11 | 1994-06-28 | Allergan, Inc. | Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
US5344959A (en) * | 1993-05-18 | 1994-09-06 | Allergan, Inc. | Tetrahydronaphthyl and cyclopropyl substituted 1,3-butadienes having retinoid-like activity |
-
1992
- 1992-06-11 US US07/898,764 patent/US5324840A/en not_active Expired - Fee Related
-
1993
- 1993-06-01 JP JP50153294A patent/JP3520085B2/en not_active Expired - Fee Related
- 1993-06-01 CA CA002137819A patent/CA2137819A1/en not_active Abandoned
- 1993-06-01 EP EP93915168A patent/EP0649409A1/en not_active Withdrawn
- 1993-06-01 WO PCT/US1993/005153 patent/WO1993025530A2/en not_active Application Discontinuation
- 1993-06-01 AU AU45255/93A patent/AU687741B2/en not_active Ceased
- 1993-06-07 IL IL10593793A patent/IL105937A/en not_active IP Right Cessation
- 1993-06-07 ZA ZA933994A patent/ZA933994B/en unknown
- 1993-06-11 CN CN93108417A patent/CN1144091A/en active Pending
-
1994
- 1994-03-23 US US08/216,990 patent/US6624188B1/en not_active Expired - Fee Related
- 1994-06-15 US US08/260,181 patent/US5475113A/en not_active Expired - Fee Related
-
2003
- 2003-10-15 JP JP2003354915A patent/JP2004091494A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4326055A (en) * | 1977-12-22 | 1982-04-20 | Hoffmann-La Roche Inc. | Stilbene derivatives |
US4723028A (en) * | 1984-07-07 | 1988-02-02 | Koichi Shudo | Stilbene derivatives |
EP0176032A2 (en) * | 1984-09-22 | 1986-04-02 | BASF Aktiengesellschaft | Tetralin derivatives, their preparation and use |
EP0210929A2 (en) * | 1985-07-25 | 1987-02-04 | Centre International De Recherches Dermatologiques Galderma - Cird Galderma | Aromatic polycyclic derivatives, process for their preparation and their pharmaceutical and cosmetic use |
EP0245825A1 (en) * | 1986-05-09 | 1987-11-19 | Warner-Lambert Company | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
DE3715955A1 (en) * | 1986-05-23 | 1987-11-26 | Hoffmann La Roche | TETRAHYDRONAPHTHALINE AND INDANDERIVATES |
EP0253302A2 (en) * | 1986-07-15 | 1988-01-20 | F. Hoffmann-La Roche Ag | Tetrahydronaphthalène and indane derivatives, their synthesis and application in pharmaceutical preparations |
EP0303915A2 (en) * | 1987-08-19 | 1989-02-22 | F. Hoffmann-La Roche Ag | Retinoids for the treatment of skin damaged by light |
WO1991016051A1 (en) * | 1990-04-16 | 1991-10-31 | Rhône-Poulenc Rorer International (Holdings) Inc. | Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0909560A2 (en) * | 1993-03-11 | 1999-04-21 | Allergan, Inc. | Treatment o tumors with compounds having RXR retinoid receptor agoinst activity |
EP0909560A3 (en) * | 1993-03-11 | 2002-05-22 | Allergan, Inc. | Treatment o tumors with compounds having RXR retinoid receptor agoinst activity |
US5798372A (en) * | 1995-03-20 | 1998-08-25 | Allergan | Method for preventing onset of restenosis after angioplasty employing a retinoid |
WO2002004439A2 (en) * | 2000-07-10 | 2002-01-17 | F. Hoffmann-La Roche Ag | Thiophene retinoids |
WO2002004439A3 (en) * | 2000-07-10 | 2002-09-26 | Hoffmann La Roche | Thiophene retinoids |
AU2001289619B2 (en) * | 2000-07-10 | 2006-07-13 | F. Hoffmann-La Roche Ag | Thiophene retinoids |
US10406088B2 (en) | 2015-01-20 | 2019-09-10 | TetraDerm Group LLC | Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration |
Also Published As
Publication number | Publication date |
---|---|
JP2004091494A (en) | 2004-03-25 |
JP3520085B2 (en) | 2004-04-19 |
CN1144091A (en) | 1997-03-05 |
IL105937A (en) | 2001-04-30 |
US5324840A (en) | 1994-06-28 |
JPH07508725A (en) | 1995-09-28 |
EP0649409A1 (en) | 1995-04-26 |
IL105937A0 (en) | 1993-10-20 |
AU687741B2 (en) | 1998-03-05 |
US6624188B1 (en) | 2003-09-23 |
WO1993025530A3 (en) | 1994-03-17 |
AU4525593A (en) | 1994-01-04 |
CA2137819A1 (en) | 1993-12-23 |
ZA933994B (en) | 1994-01-07 |
US5475113A (en) | 1995-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU687741B2 (en) | Vinyl arenas having retinoid-like activity | |
DE3839330A1 (en) | Liquid-crystalline cyclopropylalkyl- or -alkenyl-heterocycles, process for their preparation, and their use in liquid-crystalline mixtures | |
EP0573878B1 (en) | 3-fluoropyridines, process for their preparation and their use in liquid crystal mixtures | |
EP0563146B1 (en) | 2-fluoropyridine, process for producing it and its use in liquid crystal mixtures | |
EP0398155B1 (en) | Cyclopropylalkyl or cycloalkenyl compounds, process for their preparation and their use in liquid crystal mixtures | |
DE19653008A1 (en) | Fluorinated phenanthrene derivatives and their use in liquid crystalline mixtures | |
DE19652252A1 (en) | 1,3-difluoronaphthalene derivatives and their use in liquid crystalline mixtures | |
DE19720289A1 (en) | New 9-fluoro- and 9,9-di:fluoro-9H-fluorene compounds | |
EP0428665B1 (en) | Fluorophenyl pyrimidines | |
EP0532916B1 (en) | 2-Fluoropyrazines, process for their preparation, and their use in liquid crystalline mixtures | |
EP0475444B1 (en) | Use of 4-fluoro-pyrimidine derivatives as components for ferroelectric liquid crystal mixtures and process to prepare these compounds | |
DE4315867A1 (en) | 3-Chloropyridines, process for their preparation, and their use in liquid-crystal mixtures | |
EP0639189B1 (en) | Pyridylpyrimidines, a method of preparing them, and their use in liquid-crystal mixtures | |
DE4030603C2 (en) | New pyridyl pyrimidine cpds. for liq. crystal mediums - has chiral tilted smectic phase with wide ferroelectric phase range and favourable viscosity | |
DE19652247A1 (en) | 5,7-difluoro-1,2,3,4-tetrahydronaphthalene derivatives and their use in liquid-crystalline mixtures | |
EP0743971B1 (en) | Phenanthridine derivatives and their use in liquid crystal mixtures | |
DE19538404B4 (en) | Difluoroquinoline derivatives and liquid crystal mixtures containing them, and switching and / or display device | |
EP0428720A1 (en) | Optically active compounds and liquid crystal phase. | |
DE19652250A1 (en) | 1,1,5,7-tetrafluoro-1,2,3,4-tetrahydronaphthalene derivatives and their use in liquid-crystalline mixtures | |
DE19653009A1 (en) | 6-fluorophenanthridine derivatives and their use in liquid-crystalline mixtures | |
DE19653010A1 (en) | 9,9-difluoro-9,10-dihydrophenanthrene derivatives and their use in liquid-crystalline mixtures | |
EP0433826B1 (en) | Fluorophenylpyridines | |
DE4029165A1 (en) | 4-Fluoro-pyrimidine cpds. used as components of liq. crystal mixts. | |
DE19652249A1 (en) | 1,3,5-trifluoronaphthalene derivatives and their use in liquid crystalline mixtures | |
DE4111461A1 (en) | New 2-fluoro-pyridine cpds. used in ferroelectric liquid crystal mixt. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: DESCRIPTION,CLAIMS AND INTERNATIONAL SEARCH REPORT REPLACED BY CORRECT DESCRIPTION,CLAIMS AND INTERNATIONAL SEARCH REPORT;PAGES 1/9-9/9,DRAWINGS,ADDED |
|
XX | Miscellaneous: |
Free format text: IN PCT GAZETTE 05/94,PAGE 2685,UNDER "CORRECTED VERSIONS OF PAMPHLETS",THE CORRECTION RELATING TO"WO 93/25530,PCT/US93/05153"SHOULD READ"DESCRIPTION AND CLAIMS REPLACED BY CORRECT DESCRIPTION AND CLAIMS;PAGES 1/9-9/9,DRAWINGS,ADDED;INTERNATIONAL SEARCH REPORT CANCELLED" |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 13-42,DESCRIPTION,REPLACED BY NEW PAGES 13-42;AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2137819 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993915168 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1993915168 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993915168 Country of ref document: EP |